Aster DM Healthcare announced that the National Company Law Tribunal (NCLT) has approved the scheme of amalgamation between Aster DM Healthcare Limited and Quality Care India Limited. The approval was granted on January 21, 2026. Meetings for equity shareholders and unsecured trade creditors will be convened between February 27, 2026, and March 13, 2026, to consider the proposed scheme.
Amalgamation Scheme Gets the Green Light
The National Company Law Tribunal (NCLT), Hyderabad Bench, has approved the scheme of amalgamation involving Aster DM Healthcare Limited (“Transferee Company”) and Quality Care India Limited (“Transferor Company”). The approval was formalized through an order issued on January 21, 2026.
Shareholder and Creditor Meetings
As a result of the NCLT order, meetings will be held to seek further approvals for the scheme:
- Equity Shareholders: A meeting for the equity shareholders of Aster DM Healthcare Limited is scheduled to take place between February 27, 2026, and March 13, 2026. This meeting will be held physically or via video conferencing/audio-visual means.
- Unsecured Trade Creditors: A separate meeting for the unsecured trade creditors of Aster DM Healthcare Limited will also be convened between February 27, 2026, and March 13, 2026, utilizing the same physical or video conferencing/audio-visual formats.
- Secured Creditors: The requirement for a meeting of the secured creditors of the Transferee Company has been dispensed with.
Details of the Applicant Companies
Quality Care India Limited (Transferor Company):
- Incorporated on September 7, 1992.
- Paid-up share capital: Rs. 3,809,205,520
Aster DM Healthcare Limited (Transferee Company):
- Incorporated on January 18, 2008.
- Paid-up share capital: Rs. 5,181,210,290
Benefits of the Amalgamation
The proposed amalgamation aims to provide the following benefits:
- Scale and financial resilience
- Diversification and Prudential for growth
- Streamlining processes, functions and resources
Key Details of Meetings
- A meeting of the Equity Shareholders is scheduled to be held from February 27, 2026 to March 13, 2026.
- The Equity Shareholders will be held within the period from February 27, 2026 to March 13, 2026 of this order at the convenient time at the registered office of the Applicant Companies through Physically, Video Conferencing/Other Audio-Visual Mode.
- A separate meeting for the Unsecured Trade Creditors is scheduled from February 27, 2026 to March 13, 2026.
- The number of Equity Shareholders for the Transferor Company is fixed as 5. The number of Equity Shareholders for the Transferee Company is fixed as 30.
- The number of Unsecured Trade Creditors for the Transferor Company is fixed as 5. The number of Unsecured Trade Creditors for the Transferee Company is fixed as 30.
Source: BSE
